PLYMOUTH MEETING, Pa., Nov. 11, 2025 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people...
INOVIO Announces Pricing of $25 Million Public Offering